Abbott Laboratories (ABT) Change in Inventory (2009 - 2026)

Abbott Laboratories has disclosed Change in Inventory across 18 years of filings, most recently posting $420.0 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $420.0 million, up 64.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.0 million (up 69.07% YoY), and the FY2025 annual result was -$195.0 million, down 436.21% from the prior year.
• Change in Inventory came in at $420.0 million for Q1 2026 at Abbott Laboratories, up from -$234.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $554.0 million in Q1 2022 to a low of -$295.0 million in Q4 2023.
• The 5-year median for Change in Inventory is $189.0 million (2022), against an average of $113.4 million.
• Across the five-year window, Change in Inventory surged 9420.0% in 2022 and plunged 256.08% in 2023, its largest moves.
• Abbott Laboratories' Change in Inventory stood at $189.0 million in 2022, then slumped by 256.08% to -$295.0 million in 2023, then advanced by 20.34% to -$235.0 million in 2024, then increased by 0.43% to -$234.0 million in 2025, then soared by 279.49% to $420.0 million in 2026.
• The last three Change in Inventory figures came in at $420.0 million (Q1 2026), -$234.0 million (Q4 2025), and -$213.0 million (Q3 2025), per Business Quant data.